Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q43634488)
Watch
English
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma.
scientific article published in April 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
title
A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
main subject
phase II clinical trial
0 references
irinotecan
1 reference
based on heuristic
inferred from title
author
Leonard B. Saltz
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Eileen M. O'Reilly
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
author name string
P M Sanz-Altamira
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
K E Stuart
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
L Raeburn
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
C Steger
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
N E Kemeny
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
publication date
1 April 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
published in
Annals of Oncology
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
volume
12
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
page(s)
501-504
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
cites work
Cancer statistics, 1998.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 1999.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biliary tract cancers.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lymph node spread from carcinoma of the gallbladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary carcinoma of the gallbladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary carcinoma of the gallbladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of Aggressive Surgery for Carcinoma of the Extrahepatic Bile Ducts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk factors for gallbladder cancer. An international collaborative case-control study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of cisplatin in patients with biliary tract carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The role of chemotherapy in the treatment of bile duct cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma: a case report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adriamycin, BCNU, ftorafur chemotherapy of pancreatic and biliary tract cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1023%2FA%3A1011135014895
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1023/A:1011135014895
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
PubMed ID
11398883
1 reference
stated in
Europe PubMed Central
PubMed ID
11398883
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11398883%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
